LAZZARI, LORENZO
 Distribuzione geografica
Continente #
EU - Europa 158
NA - Nord America 154
AS - Asia 76
OC - Oceania 3
SA - Sud America 1
Totale 392
Nazione #
US - Stati Uniti d'America 154
IT - Italia 86
SE - Svezia 49
CN - Cina 41
IN - India 17
SG - Singapore 15
RU - Federazione Russa 14
DE - Germania 5
AU - Australia 3
HK - Hong Kong 3
NL - Olanda 2
AT - Austria 1
BR - Brasile 1
ES - Italia 1
Totale 392
Città #
Milan 28
Ashburn 27
Shanghai 18
New York 17
Pune 12
Moscow 11
Lawrence 10
Princeton 10
Rome 9
Singapore 7
Boardman 4
Bologna 4
Chandler 4
Dallas 4
Torre Annunziata 4
Beijing 3
Brescia 3
Mumbai 3
Shenzhen 3
Avellino 2
Borgomanero 2
Carpenedolo 2
Castelseprio 2
Chaoyang 2
Chennai 2
Hong Kong 2
Lissone 2
Novara 2
Ome 2
Venezia 2
Verona 2
Washington 2
Baoding 1
Elmendorf 1
Guangzhou 1
Jiaxing 1
Logroño 1
Naaldwijk 1
Newark 1
Nuremberg 1
Pisa 1
Sydney 1
São Paulo 1
Vienna 1
Wuhu 1
Wuxi 1
Totale 221
Nome #
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 51
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 32
Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura 29
Fiberoptic endoscopic evaluation of swallowing in early-to-advanced stage Huntington’s disease 29
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide 26
PS1268 CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS 25
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome 25
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation 24
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial 23
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 23
Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation 21
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type 21
Standardized GMP-compliant scalable production of human pancreas organoids 18
Erratum: Lung ultrasound to evaluate invasive fungal diseases after allogeneic hematopoietic stem cell transplantation (Infection and Chemotherapy (2019) 51: 4 (386-392) DOI: 10.3947/ic.2019.51.4.386) 17
CMV-specific T Cell Counts Early after Allogeneic Hematopoietic Stem Cell Transplantation Stratify the Risk of Subsequent CMV Reactivations: Results of a Prospective Observational Study 15
Complicated and persistent severe COVID-19 pneumonia in a recipient of allogeneic haematopoietic stem cell transplant 15
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia 14
Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft-versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases 9
Totale 417
Categoria #
all - tutte 4.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.354


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 1 0 0 0
2020/20213 0 0 0 1 0 0 1 1 0 0 0 0
2021/202221 0 0 0 3 0 0 0 10 4 0 1 3
2022/2023134 22 18 5 3 16 14 2 16 16 4 14 4
2023/2024156 12 7 21 21 21 39 0 24 0 0 1 10
2024/2025102 35 28 22 12 5 0 0 0 0 0 0 0
Totale 417